chr3-151355245-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001393769.1(MED12L):​c.2517+6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.701 in 1,590,704 control chromosomes in the GnomAD database, including 395,713 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 45424 hom., cov: 31)
Exomes 𝑓: 0.69 ( 350289 hom. )

Consequence

MED12L
NM_001393769.1 splice_region, intron

Scores

2
Splicing: ADA: 0.002986
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.661

Publications

14 publications found
Variant links:
Genes affected
MED12L (HGNC:16050): (mediator complex subunit 12L) The protein encoded by this gene is part of the Mediator complex, which is involved in transcriptional coactivation of nearly all RNA polymerase II-dependent genes. The Mediator complex links gene-specific transcriptional activators with the basal transcription machinery. [provided by RefSeq, May 2010]
P2RY12 (HGNC:18124): (purinergic receptor P2Y12) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
P2RY12 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 8
    Inheritance: AD, AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 3-151355245-T-C is Benign according to our data. Variant chr3-151355245-T-C is described in ClinVar as Benign. ClinVar VariationId is 1321163.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.912 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001393769.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED12L
NM_001393769.1
MANE Select
c.2517+6T>C
splice_region intron
N/ANP_001380698.1
P2RY12
NM_022788.5
MANE Select
c.-179-14485A>G
intron
N/ANP_073625.1
MED12L
NM_053002.6
c.2412+6T>C
splice_region intron
N/ANP_443728.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED12L
ENST00000687756.1
MANE Select
c.2517+6T>C
splice_region intron
N/AENSP00000508695.1
P2RY12
ENST00000302632.4
TSL:1 MANE Select
c.-179-14485A>G
intron
N/AENSP00000307259.4
MED12L
ENST00000474524.5
TSL:1
c.2412+6T>C
splice_region intron
N/AENSP00000417235.1

Frequencies

GnomAD3 genomes
AF:
0.765
AC:
116267
AN:
151978
Hom.:
45371
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.919
Gnomad AMI
AF:
0.689
Gnomad AMR
AF:
0.770
Gnomad ASJ
AF:
0.697
Gnomad EAS
AF:
0.854
Gnomad SAS
AF:
0.858
Gnomad FIN
AF:
0.740
Gnomad MID
AF:
0.797
Gnomad NFE
AF:
0.665
Gnomad OTH
AF:
0.773
GnomAD2 exomes
AF:
0.748
AC:
185309
AN:
247806
AF XY:
0.745
show subpopulations
Gnomad AFR exome
AF:
0.926
Gnomad AMR exome
AF:
0.817
Gnomad ASJ exome
AF:
0.709
Gnomad EAS exome
AF:
0.849
Gnomad FIN exome
AF:
0.735
Gnomad NFE exome
AF:
0.665
Gnomad OTH exome
AF:
0.728
GnomAD4 exome
AF:
0.694
AC:
998275
AN:
1438608
Hom.:
350289
Cov.:
25
AF XY:
0.698
AC XY:
500692
AN XY:
716958
show subpopulations
African (AFR)
AF:
0.930
AC:
30568
AN:
32874
American (AMR)
AF:
0.813
AC:
35410
AN:
43544
Ashkenazi Jewish (ASJ)
AF:
0.706
AC:
18294
AN:
25920
East Asian (EAS)
AF:
0.843
AC:
33345
AN:
39544
South Asian (SAS)
AF:
0.846
AC:
71991
AN:
85062
European-Finnish (FIN)
AF:
0.727
AC:
38786
AN:
53362
Middle Eastern (MID)
AF:
0.847
AC:
4848
AN:
5726
European-Non Finnish (NFE)
AF:
0.661
AC:
722010
AN:
1093010
Other (OTH)
AF:
0.722
AC:
43023
AN:
59566
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
14638
29276
43915
58553
73191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18834
37668
56502
75336
94170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.765
AC:
116382
AN:
152096
Hom.:
45424
Cov.:
31
AF XY:
0.772
AC XY:
57423
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.919
AC:
38167
AN:
41518
American (AMR)
AF:
0.771
AC:
11768
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.697
AC:
2419
AN:
3470
East Asian (EAS)
AF:
0.855
AC:
4420
AN:
5172
South Asian (SAS)
AF:
0.857
AC:
4133
AN:
4824
European-Finnish (FIN)
AF:
0.740
AC:
7814
AN:
10566
Middle Eastern (MID)
AF:
0.786
AC:
231
AN:
294
European-Non Finnish (NFE)
AF:
0.665
AC:
45173
AN:
67954
Other (OTH)
AF:
0.771
AC:
1629
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1332
2663
3995
5326
6658
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.703
Hom.:
81914
Bravo
AF:
0.773
Asia WGS
AF:
0.824
AC:
2867
AN:
3478
EpiCase
AF:
0.675
EpiControl
AF:
0.676

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nizon-Isidor syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
15
DANN
Benign
0.91
PhyloP100
-0.66
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0030
dbscSNV1_RF
Benign
0.17
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7615865; hg19: chr3-151073033; COSMIC: COSV56381353; COSMIC: COSV56381353; API